J0207 HCPCS Level II code: Injection, amifostine, 500 mg

J0207 is the HCPCS code for “Injection, amifostine, 500 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J0207

Injection, amifostine, 500 mg

Short description: Amifostine

HCPCS · United States

Medicare details

The indicators CMS publishes with J0207 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Special coverage instructions apply
Medicare pricing
Drugs
Type of service
Medical care; Lump sum purchase of DME, prosthetics, orthotics
BETOS category
Chemotherapy
Added
Jan 1, 1998

Where J0207 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J0207Injection, amifostine, 500 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J0207 mean?

J0207 is the HCPCS code for “Injection, amifostine, 500 mg” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J0207?

CMS lists J0207’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.